Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells

If you need an accessible version of this item, please email your request to digschol@iu.edu so that they may create one and provide it to you.
Date
2019-10
Language
English
Embargo Lift Date
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
AACR
Abstract

Natural killer (NK) cells generate proinflammatory cytokines that are required to contain infections and tumor growth. However, the posttranscriptional mechanisms that regulate NK cell functions are not fully understood. Here, we define the role of the microRNA cluster known as Mirc11 (which includes miRNA-23a, miRNA-24a, and miRNA-27a) in NK cell–mediated proinflammatory responses. Absence of Mirc11 did not alter the development or the antitumor cytotoxicity of NK cells. However, loss of Mirc11 reduced generation of proinflammatory factors in vitro and interferon-γ–dependent clearance of Listeria monocytogenes or B16F10 melanoma in vivo by NK cells. These functional changes resulted from Mirc11 silencing ubiquitin modifiers A20, Cbl-b, and Itch, allowing TRAF6-dependent activation of NF-κB and AP-1. Lack of Mirc11 caused increased translation of A20, Cbl-b, and Itch proteins, resulting in deubiquitylation of scaffolding K63 and addition of degradative K48 moieties on TRAF6. Collectively, our results describe a function of Mirc11 that regulates generation of proinflammatory cytokines from effector lymphocytes.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Nanbakhsh, A., Srinivasamani, A., Holzhauer, S., Riese, M. J., Zheng, Y., Wang, D., Burns, R., Reimer, M. H., Rao, S., Lemke, A., Tsaih, S.-W., Flister, M. J., Lao, S., Dahl, R., Thakar, M. S., & Malarkannan, S. (2019). Mirc11 Disrupts Inflammatory but Not Cytotoxic Responses of NK Cells. Cancer Immunology Research, 7(10), 1647–1662. https://doi.org/10.1158/2326-6066.CIR-18-0934
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Cancer Immunology Research
Source
Author
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}